Innospec Total Stockholder Equity vs Deferred Long Term Liab Analysis

IOSP Stock

USD 129.50 0.07 0.05%

Innospec financial indicator trend analysis is infinitely more than just investigating Innospec recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Innospec is a good investment. Please check the relationship between Innospec Total Stockholder Equity and its Deferred Long Term Liab accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

To learn how to invest in Innospec Stock, please use our How to Invest in Innospec guide.

Total Stockholder Equity vs Deferred Long Term Liab

Total Stockholder Equity vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Innospec Total Stockholder Equity account and Deferred Long Term Liab. At this time, the significance of the direction appears to have strong relationship.

The correlation between Innospec's Total Stockholder Equity and Deferred Long Term Liab is 0.74. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Innospec, assuming nothing else is changed. The correlation between historical values of Innospec's Total Stockholder Equity and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Innospec are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Total Stockholder Equity i.e., Innospec's Total Stockholder Equity and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.74

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Innospec's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Innospec current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

To learn how to invest in Innospec Stock, please use our How to Invest in Innospec guide.At this time, Innospec's Selling General Administrative is relatively stable compared to the past year. As of 05/18/2024, Enterprise Value Over EBITDA is likely to grow to 14.38, while Tax Provision is likely to drop slightly above 43.6 M.

	2021	2022	2023	2024 (projected)
Gross Profit	434.9M	586.7M	582.8M	318.7M
Total Revenue	1.5B	2.0B	1.9B	2.0B

Gross Profit Total Revenue

Innospec fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		-0.09	0.84	0.91	0.84	0.81	-0.34	0.79	0.89	0.58	0.93	0.11	0.56	0.79	0.01	0.31	0.87	-0.26	0.4	0.83	0.53	0.77	-0.02	-0.21	0.36	0.36
Short Long Term Debt Total	-0.09		-0.41	-0.26	-0.39	-0.28	0.91	-0.47	-0.26	-0.37	0.15	0.18	-0.38	-0.35	0.48	0.87	-0.39	-0.02	0.09	0.41	-0.34	-0.43	0.54	0.84	-0.51	-0.51
Other Current Liab	0.84	-0.41		0.89	0.75	0.62	-0.58	0.75	0.8	0.57	0.65	0.02	0.57	0.7	-0.09	-0.09	0.94	-0.28	0.22	0.53	0.41	0.75	-0.34	-0.44	0.54	0.54
Total Current Liabilities	0.91	-0.26	0.89		0.8	0.79	-0.45	0.75	0.97	0.57	0.76	0.34	0.55	0.83	0.07	0.06	0.93	-0.25	0.55	0.72	0.56	0.81	0.07	-0.25	0.24	0.24
Total Stockholder Equity	0.84	-0.39	0.75	0.8		0.96	-0.66	0.98	0.76	0.84	0.75	0.12	0.82	0.95	-0.43	0.0	0.76	-0.05	0.41	0.61	0.83	0.96	-0.1	-0.47	0.36	0.37
Property Plant And Equipment Net	0.81	-0.28	0.62	0.79	0.96		-0.54	0.92	0.77	0.76	0.76	0.32	0.74	0.94	-0.3	0.05	0.69	-0.05	0.57	0.63	0.88	0.91	0.14	-0.34	0.15	0.16
Net Debt	-0.34	0.91	-0.58	-0.45	-0.66	-0.54		-0.73	-0.42	-0.72	-0.09	0.09	-0.72	-0.6	0.57	0.72	-0.55	-0.07	-0.07	0.14	-0.61	-0.7	0.49	0.85	-0.55	-0.56
Retained Earnings	0.79	-0.47	0.75	0.75	0.98	0.92	-0.73		0.71	0.86	0.66	0.03	0.86	0.93	-0.54	-0.09	0.76	0.04	0.3	0.51	0.83	0.97	-0.24	-0.58	0.48	0.49
Accounts Payable	0.89	-0.26	0.8	0.97	0.76	0.77	-0.42	0.71		0.5	0.73	0.32	0.48	0.82	0.08	0.08	0.9	-0.17	0.54	0.71	0.55	0.78	0.1	-0.27	0.25	0.24
Cash	0.58	-0.37	0.57	0.57	0.84	0.76	-0.72	0.86	0.5		0.43	0.12	1.0	0.78	-0.52	-0.15	0.55	0.17	0.31	0.35	0.83	0.88	-0.16	-0.5	0.36	0.37
Non Current Assets Total	0.93	0.15	0.65	0.76	0.75	0.76	-0.09	0.66	0.73	0.43		0.1	0.41	0.68	0.08	0.54	0.66	-0.33	0.41	0.9	0.46	0.62	0.14	0.03	0.17	0.17
Non Currrent Assets Other	0.11	0.18	0.02	0.34	0.12	0.32	0.09	0.03	0.32	0.12	0.1		0.11	0.25	0.45	0.01	0.09	-0.03	0.85	0.26	0.35	0.18	0.81	0.41	-0.7	-0.7
Cash And Short Term Investments	0.56	-0.38	0.57	0.55	0.82	0.74	-0.72	0.86	0.48	1.0	0.41	0.11		0.77	-0.54	-0.16	0.54	0.19	0.3	0.34	0.82	0.87	-0.18	-0.5	0.37	0.38
Net Receivables	0.79	-0.35	0.7	0.83	0.95	0.94	-0.6	0.93	0.82	0.78	0.68	0.25	0.77		-0.4	0.01	0.76	0.07	0.49	0.64	0.86	0.97	0.02	-0.41	0.27	0.28
Common Stock Shares Outstanding	0.01	0.48	-0.09	0.07	-0.43	-0.3	0.57	-0.54	0.08	-0.52	0.08	0.45	-0.54	-0.4		0.29	-0.09	-0.41	0.34	0.15	-0.45	-0.48	0.57	0.66	-0.51	-0.52
Non Current Liabilities Total	0.31	0.87	-0.09	0.06	0.0	0.05	0.72	-0.09	0.08	-0.15	0.54	0.01	-0.16	0.01	0.29		-0.05	-0.05	0.12	0.72	-0.12	-0.09	0.37	0.66	-0.22	-0.22
Inventory	0.87	-0.39	0.94	0.93	0.76	0.69	-0.55	0.76	0.9	0.55	0.66	0.09	0.54	0.76	-0.09	-0.05		-0.2	0.28	0.58	0.44	0.79	-0.24	-0.49	0.52	0.52
Other Current Assets	-0.26	-0.02	-0.28	-0.25	-0.05	-0.05	-0.07	0.04	-0.17	0.17	-0.33	-0.03	0.19	0.07	-0.41	-0.05	-0.2		0.02	-0.15	0.32	0.09	-0.13	-0.07	0.12	0.13
Other Stockholder Equity	0.4	0.09	0.22	0.55	0.41	0.57	-0.07	0.3	0.54	0.31	0.41	0.85	0.3	0.49	0.34	0.12	0.28	0.02		0.49	0.53	0.42	0.71	0.33	-0.55	-0.55
Total Liab	0.83	0.41	0.53	0.72	0.61	0.63	0.14	0.51	0.71	0.35	0.9	0.26	0.34	0.64	0.15	0.72	0.58	-0.15	0.49		0.39	0.56	0.32	0.26	-0.01	-0.01
Property Plant And Equipment Gross	0.53	-0.34	0.41	0.56	0.83	0.88	-0.61	0.83	0.55	0.83	0.46	0.35	0.82	0.86	-0.45	-0.12	0.44	0.32	0.53	0.39		0.85	0.1	-0.35	0.14	0.14
Total Current Assets	0.77	-0.43	0.75	0.81	0.96	0.91	-0.7	0.97	0.78	0.88	0.62	0.18	0.87	0.97	-0.48	-0.09	0.79	0.09	0.42	0.56	0.85		-0.12	-0.51	0.37	0.38
Short Term Debt	-0.02	0.54	-0.34	0.07	-0.1	0.14	0.49	-0.24	0.1	-0.16	0.14	0.81	-0.18	0.02	0.57	0.37	-0.24	-0.13	0.71	0.32	0.1	-0.12		0.69	-0.9	-0.9
Intangible Assets	-0.21	0.84	-0.44	-0.25	-0.47	-0.34	0.85	-0.58	-0.27	-0.5	0.03	0.41	-0.5	-0.41	0.66	0.66	-0.49	-0.07	0.33	0.26	-0.35	-0.51	0.69		-0.76	-0.76
Common Stock Total Equity	0.36	-0.51	0.54	0.24	0.36	0.15	-0.55	0.48	0.25	0.36	0.17	-0.7	0.37	0.27	-0.51	-0.22	0.52	0.12	-0.55	-0.01	0.14	0.37	-0.9	-0.76		1.0
Common Stock	0.36	-0.51	0.54	0.24	0.37	0.16	-0.56	0.49	0.24	0.37	0.17	-0.7	0.38	0.28	-0.52	-0.22	0.52	0.13	-0.55	-0.01	0.14	0.38	-0.9	-0.76	1.0

Click cells to compare fundamentals

Innospec Account Relationship Matchups

Innospec fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.5B	1.4B	1.6B	1.6B	1.7B	1.0B
Short Long Term Debt Total	92.6M	40.8M	35.6M	45.3M	45.2M	42.9M
Other Current Liab	169.9M	141.9M	175.4M	226.6M	191.5M	109.6M
Total Current Liabilities	303.5M	252.4M	336.6M	405.8M	371.5M	233.9M
Total Stockholder Equity	918.9M	944.9M	1.0B	1.0B	1.1B	1.2B
Property Plant And Equipment Net	231.1M	250.9M	249.8M	266.2M	313.4M	329.1M
Net Debt	16.9M	(64.5M)	(106.2M)	(101.8M)	(158.5M)	(150.6M)
Retained Earnings	755.5M	758.6M	822.9M	924.2M	1.0B	1.1B
Accounts Payable	122M	98.7M	148.7M	165.3M	163.6M	88.4M
Cash	75.7M	105.3M	141.8M	147.1M	203.7M	213.9M
Non Current Assets Total	838.5M	831.2M	842.8M	731.1M	821.7M	601.2M
Non Currrent Assets Other	5.9M	8.2M	5M	55.2M	41.3M	32.5M
Cash And Short Term Investments	75.7M	105.3M	141.8M	147.1M	203.7M	213.9M
Net Receivables	292M	221.4M	284.5M	334.6M	359.8M	377.8M
Common Stock Shares Outstanding	24.7M	24.8M	24.9M	25.0M	25.0M	20.1M
Liabilities And Stockholders Equity	1.5B	1.4B	1.6B	1.6B	1.7B	1.0B
Non Current Liabilities Total	246.4M	200.1M	201.3M	157.5M	186.3M	170.8M
Inventory	244.6M	220M	277.6M	373.1M	300.1M	169.6M
Other Current Assets	1.1M	13.1M	800K	400K	22.1M	23.2M
Other Stockholder Equity	237.5M	243.3M	256.7M	261.1M	266.7M	258.5M
Total Liab	549.9M	452.5M	537.9M	563.3M	557.8M	468.7M
Property Plant And Equipment Gross	231.1M	250.9M	249.8M	266.2M	637.4M	669.3M
Total Current Assets	630.3M	566.2M	728.1M	872.6M	885.7M	930.0M
Accumulated Other Comprehensive Income	(74.4M)	(57.3M)	(46.9M)	(145.2M)	(148.1M)	(140.7M)
Short Term Debt	11.6M	11.8M	12.5M	13.9M	13.6M	20.3M
Intangible Assets	113.5M	75.3M	57.5M	45M	57.3M	54.4M
Other Liab	165.4M	171.1M	178.2M	126.1M	145.0M	101.8M
Other Assets	130.9M	175M	171.2M	61.1M	70.3M	86.2M
Good Will	363M	371.2M	364.3M	358.8M	399.3M	304.3M
Property Plant Equipment	198.7M	210.8M	249.8M	220.9M	254.0M	266.7M
Net Tangible Assets	463.9M	526.8M	611.2M	634.2M	729.3M	765.8M
Retained Earnings Total Equity	755.5M	758.6M	822.9M	924.2M	1.1B	628.1M
Long Term Debt Total	205.8M	187.7M	59.1M	100K	115K	109.3K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Innospec is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Innospec Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Innospec Stock. Highlighted below are key reports to facilitate an investment decision about Innospec Stock:

How To Invest In Innospec

Details

Is Innospec Stock a good investment?

Details

What is Innospec's Net Worth?

Details

Largest Specialty Chemicals Companies

View

Largest Basic Materials Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

To learn how to invest in Innospec Stock, please use our How to Invest in Innospec guide.

You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Innospec Stock analysis

When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.

	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments

Is Innospec's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innospec. If investors know Innospec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innospec listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.241

Dividend Share

1.41

Earnings Share

5.88

Revenue Per Share

77.969

Quarterly Revenue Growth

(0.02)

The market value of Innospec is measured differently than its book value, which is the value of Innospec that is recorded on the company's balance sheet. Investors also form their own opinion of Innospec's value that differs from its market value or its book value, called intrinsic value, which is Innospec's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innospec's market value can be influenced by many factors that don't directly affect Innospec's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Innospec's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innospec is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innospec's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Innospec Total Stockholder Equity vs Deferred Long Term Liab Analysis

Total Stockholder Equity vs Deferred Long Term Liab

Total Stockholder Equity vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Total Stockholder Equity

Deferred Long Term Liab

Innospec fundamental ratios Correlations

Innospec Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Innospec fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Innospec Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Retained Earnings	+ 0.98	Total Stockholder Equity
Accounts Payable	+ 0.97	Total Current Liabilities
Total Current Assets	+ 0.97	Retained Earnings
Total Current Assets	+ 0.97	Net Receivables

Common Stock	- 0.9	Short Term Debt
Common Stock Total Equity	- 0.9	Short Term Debt
Common Stock	- 0.76	Intangible Assets
Common Stock Total Equity	- 0.76	Intangible Assets
Retained Earnings	- 0.73	Net Debt
Cash And Short Term Investments	- 0.72	Net Debt